Cargando…
Emerging Metabolic Therapies in Pulmonary Arterial Hypertension
Pulmonary hypertension (PH) is an enigmatic vascular disorder characterized by pulmonary vascular remodeling and increased pulmonary vascular resistance, ultimately resulting in pressure overload, dysfunction, and failure of the right ventricle. Current medications for PH do not reverse or prevent d...
Autores principales: | Harvey, Lloyd D., Chan, Stephen Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406775/ https://www.ncbi.nlm.nih.gov/pubmed/28375184 http://dx.doi.org/10.3390/jcm6040043 |
Ejemplares similares
-
Endothelial dysfunction in pulmonary arterial hypertension: an evolving landscape (2017 Grover Conference Series)
por: Ranchoux, Benoît, et al.
Publicado: (2017) -
Pulmonary Arterial Stiffness: An Early and Pervasive Driver of Pulmonary Arterial Hypertension
por: Sun, Wei, et al.
Publicado: (2018) -
Obesity alters oestrogen metabolism and contributes to pulmonary arterial hypertension
por: Mair, Kirsty M., et al.
Publicado: (2019) -
Estradiol Metabolism: Crossroads in Pulmonary Arterial Hypertension
por: Tofovic, Stevan P., et al.
Publicado: (2019) -
Mitochondrial Metabolism, Redox, and Calcium Homeostasis in Pulmonary Arterial Hypertension
por: Liang, Shuxin, et al.
Publicado: (2022)